The QualityStocks Daily Friday, October 21st, 2022

Today's Top 3 Investment Newsletters

QualityStocks(CNNA) $0.0082 +115.79%

CNBC Breaking News(VRE) $15.3100 +23.27%

The Stock Dork(EFOI) $0.4900 +21.47%

The QualityStocks Daily Stock List

Energy Focus (EFOI)

MarketClub Analysis, InvestorPlace, Wall Street Resources, QualityStocks, SmallCapVoice, MarketBeat, Marketbeat.com, PennyOmega, StockMarketWatch, TraderPower, Investing Futures, StockHotTips, BUYINS.NET, CRWEFinance, DrStockPick, BestOtc, CRWEPicks, INO.com Market Report, PennyToBuck, Market Wrap Daily, VectorVest, TradersPro, SmarTrend Newsletters, Zacks, StreetInsider, Schaeffer's, Brenda Creedo, Stock Stars, Cabot Wealth, CoolPennyStocks, Stock Rich, Stock Fortune Teller, Wealthpire Inc., Daily Trade Alert, Alternative Energy, FeedBlitz, HotOTC, The Street, Top Pros' Top Picks, Stockpalooza and CRWEWallStreet reported earlier on Energy Focus (EFOI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Energy Focus Inc. (NASDAQ: EFOI) (FRA: F14) is focused on designing, developing, manufacturing, marketing and selling energy-efficient fiber optic lighting systems internationally and in the United States.

The firm operates through the sale and marketing of military maritime, industrial and commercial lighting products and research and development services. It is based in Solon, Ohio and was incorporated in 1985. Before the firm changed its name to Energy Focus Inc. in May 2007, it was known as Fiberstars Inc.

It sells its products in the spa, swimming pool, sign and commercial lighting markets through distributors, lighting and electrical contractors, independent sales representatives and direct sales employees. Additionally, the firm is party to a strategic alliance with Woodstone Energy LLC, which entails designing and implementing turnkey energy saving solutions.

The company’s commercial products include LED retrofit kits; LED vapor tight lighting fixtures; LED dock lights; LED downlights; LED fixtures for high-intensity discharge replacement in high-bay and low-bay applications and fluorescent replacement; EnFocus lighting platform, which includes color tuning and dimming; RedCap energy battery backup tubular LEDs and direct wire TLED replacements for linear fluorescent lamps. In addition to this, it also provides military maritime LED lighting products, which include Invisitube ultra-low EMI tubular LED, berth lights and fixtures, globe lights and Military Intellitube, which are used by allied foreign navies and the U.S. navy.

The company recently became an approved lighting solution technology vendor for Dalkia, a global energy services firm that’s a subsidiary of EDF Group. This move helps to further elevate sustainability, energy efficiency and wellness and with the world slowly moving towards a more sustainable way of living, both companies’ returns and investments are sure to increase in the near future.

Energy Focus (EFOI), closed Saturday's trading session at $0.49, up 21.4675%, on 22,684,138 volume. The average volume for the last 3 months is 46.872M and the stock's 52-week low/high is $0.39/$6.12.

Cann American (CNNA)

QualityStocks, Fabulous Penny Stocks, WallstreetsHotteststocks and Wallstreetbuzz reported earlier on Cann American (CNNA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Cann American Corp. (OTC: CNNA) is a development stage firm that is engaged in developing cannabis sativa strains suited for pets in different countries in the European Union.

The firm has its headquarters in Charlottenlund, Denmark and was incorporated in 2004, on August 25. It operates under the healthcare sector, under the health care facilities and Svcs sub-industry. Prior to its name change in December 2019, the firm was known as Canamed4Pets Inc.

The company, which operates as a holding firm for developing assets in the legal hemp and cannabis industries, is also involved in the development of products that are made of a blend of hemp, or cannabis sativa. It intends to distribute and market its products in all countries in the European Union by working with local distributors in every EU nation.

The firm provides supplements for horses, cats and dogs. These products are manufactured in compliance with recommendations of the GMP (Good Manufacturing Practice), the FDA (Food and Drug Administration) and the DEA (Drug Enforcement Administration). They are also made using laboratory and pharmaceutical grade equipment.

Cann American recently acquired a new subsidiary known as Hourglass Enterprises, which specializes in labeling and packaging for the cannabis industry in Oklahoma. This move will facilitate the company’s entry into the Oklahoma market, which is among the fastest growing markets in the United States. This will be beneficial to the company, which believes it can seize a significant market share via packaging given that their subsidiary is one of the few firms that operate in the market. This will encourage investments into the firm and boost growth.

Cann American (CNNA), closed Saturday's trading session at $0.0082, up 115.7895%, on 46,872,146 volume. The average volume for the last 3 months is 3.733M and the stock's 52-week low/high is $0.0015/$0.018.

Enservco (ENSV)

StockMarketWatch, QualityStocks, Streetwise Reports, MarketClub Analysis, InvestorPlace, StocksEarning, MarketBeat, StreetInsider, TradersPro, BUYINS.NET, FeedBlitz, The Bowser Report, Zacks, Wall Street Resources, Lions of Wall Street and Investing Futures reported earlier on Enservco (ENSV), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Enservco Corporation (NYSE American: ENSV) (FRA: A3O0) is engaged in the provision of fluid management as well as enhancement servicers to the onshore natural gas and oil industry in the U.S.

The firm has its headquarters in Longmont, Colorado and was founded in 1980 on February 28th by Michael D. Herman. It operates in the energy sector, under the oil and gas sub-industry. Additionally, it operates in the following regions: the Central United States region, which includes the Permian Basin and Eagle Ford Shale in Texas; the Rocky Mountain region, which is made up of eastern Montana, western North Dakota, central Wyoming, southern Wyoming and western Colorado; and the eastern U.S. region which includes eastern Ohio’s Utica Share formulation and the Marcellus Shale formation’s southern region as well as Pennsylvania, Oklahoma, New Mexico and Kansas.

The company operates through the Completion and other services and the Production services segment. The former segment is involved in the provision of frac water heating services and associated support services to the domestic gas and oil industry. On the other hand, the latter segment uses a fleet of acidizing and hot oil trucks to offer maintenance services to the domestic gas and oil industry.

The enterprise operates and owns a fleet of about 330 frac tanks, trailers, and specialized trucks. It provides well site construction, frac tank rental, fluid disposal, saltwater and freshwater hauling, scale and bacteria treatment, acidizing, pressure testing, hot oiling and frac water heating services.

The firm recently entered into partnerships with a duo of major oilfield services companies in the 1st quarter, which will bring in more investment opportunities for the company. The firm’s CEO also revealed that they would be focusing on the hot oiling service business, noting that there was potential for expansion in the space and the move would bring in additional revenue.

Enservco (ENSV), closed Saturday's trading session at $2.02, up 37.415%, on 3,733,465 volume. The average volume for the last 3 months is 1.898M and the stock's 52-week low/high is $0.5502/$8.76.

Matinas BioPharma Holdings (MTNB)

QualityStocks, MarketBeat, StockMarketWatch, TraderPower, BUYINS.NET, InvestorPlace, Marketbeat.com, Stock News Now, Zacks, StreetInsider, The Online Investor, SmallCapVoice, Schaeffer's, Tiny Gems, Trades Of The Day, Wall Street Mover, Wealth Insider Alert, FreeRealTime and Stock News reported earlier on Matinas BioPharma Holdings (MTNB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Matinas BioPharma Holdings, Inc. (NYSE American: MTNB) (FRA: 6LG) is a clinical-stage biopharmaceutical firm that is focused on the discovery and development of treatments for various indications.

The firm has its headquarters in Bedminster, New Jersey and was incorporated in May 2013 by Jerome D. Jabbour. It operates as part of the pharmaceutical and medicine industry, in the biotech and pharma sub-industry, under the health care sector. The firm has three companies in its corporate family and serves consumers in the United States.

The company is focused on enabling the delivery of life-changing medications using its lipid nano-crystals platform technology. Its technology encapsulates proteins, peptides, vaccines, oligonucleotides, small molecule drugs and other medications, making them orally bioavailable, less toxic, more tolerable and safer. The company is party to a feasibility collaboration with Genentech Inc., which entails the development of oral formulations; and research collaborations with ViiV Healthcare for the development and evaluation of formulations for antiviral drugs, as well as NINDS (National Institute of Neurological Disorders and Stroke), which entails the development of new treatments for HIV.

The enterprise's product pipeline is made up of an orally administered formulation dubbed MAT2501 which has concluded phase 1 clinical trials evaluating its effectiveness in treating intracellular bacterial infections and different types of multidrug-resistant gram negative infections and multidrug-resistant bacteria, which includes non-tuberculosis mycobacterium infections. It also develops an oral amphotericin B formulation known as MAT2203 which has been developed to prevent invasive fungal infections. The formulation is currently in phase 2 clinical trials.

The company recently announced positive safety and effectiveness data for its MAT2203 phase 2 trial. The formulation has been found to be effective in clearing fungal organisms. The success and eventual approval of the drug will be beneficial to patients and help bring in more investors into the company.

Matinas BioPharma Holdings (MTNB), closed Saturday's trading session at $0.8538, up 22.1459%, on 1,898,208 volume. The average volume for the last 3 months is 79.094M and the stock's 52-week low/high is $0.49/$1.26.

Altamira Therapeutics (CYTO)

QualityStocks, StockWireNews, StockStreetWire, Small Cap Firm, Fierce Analyst and Broad Street reported earlier on Altamira Therapeutics (CYTO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Altamira Therapeutics Ltd (NASDAQ: CYTO) is a pharmaceutical firm that is focused on the development of therapeutics that address unmet medical needs.

The firm has its headquarters in Hamilton, Bermuda and was incorporated in April 2003 by Thomas Meyer. Prior to its name change in July 2021, the firm was known as Auris Medical Holding Ltd.

The company operates primarily in Basil, Switzerland. It operates through its Australia and Switzerland geographical segments. The company serves consumers around the globe.

The enterprise’s product pipeline comprises of a formulation known as Sonsuvi, which is undergoing a phase 3 clinical trial evaluating its effectiveness in treating acute inner ear hearing loss; a formulation dubbed Keyzilen, which is undergoing a phase 3 clinical trial testing its efficacy in treating acute inner ear tinnitus; and AM-125, which is undergoing phase 2 clinical development for the intranasal treatment of vertigo. It also develops RNA therapeutics for extrahepatic therapeutic targets, which include its SemaPhore and OligoPhore platforms, which are in their preclinical stage for mRNA delivery and oligonucleotide. In addition to this, the enterprise is involved in the development of a drug-free nasal spray known as Bentrio, which has been designed to offer personal protection against airborne allergens and viruses.

The company’s Bentrio formulation which had filed for premarket clearance has been cleared by the FDA. This move brings the formulation and the company one step closer to entering the U.S. market, which will not only bring in additional revenue into the company but also encourage more investments into the firm.

Altamira Therapeutics (CYTO), closed Saturday's trading session at $0.5197, up 58.6386%, on 79,486,422 volume. The average volume for the last 3 months is 324,961 and the stock's 52-week low/high is $0.23/$3.33.

Candel Therapeutics (CADL)

QualityStocks and MarketBeat reported earlier on Candel Therapeutics (CADL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Candel Therapeutics Inc. (NASDAQ: CADL) is a clinical-stage biopharmaceutical firm that is focused on developing and commercializing cancer immunotherapy drugs.

The firm has its headquarters in Needham, Massachusetts and was incorporated in 1999 by Estuardo Aguilar-Cordova. Prior to its name change in November 2020, the firm was known as Advantagene Inc. The firm serves consumers in the United States.

The company develops oncolytic viral immunotherapies using its viral immunotherapy platform which is based on genetically modified HSV (herpes simplex virus) and adenovirus constructs. Its engineered viruses induce immunogenic death via viral-mediated cytotoxicity in diseased cells, which releases tumor neo-antigens and creates a pro-inflammatory microenvironment at a patient’s injection site. The company’s preclinical models and clinical trials use its approach.

The enterprise’s product portfolio comprises of its oncolytic HSV product candidate dubbed CAN-3110, which has been designed to improve tumor cell elimination while minimizing toxicity in health tissues. This candidate is undergoing a phase 1 clinical trial and has been developed to treat recurrent high-grade glioma. It also develops an adenovirus product candidate known as CAN-2409 (aglatimagenebesadenovec), to treat pancreatic cancer and primary prostate cancer.

The firm recently entered into a collaboration with Bionaut Labs, which explores the use of microscale robots developed by Bionaut for the delivery of oncolytic viral immunotherapy agents developed by Candel to tumors in the brain. This strategic collaboration may improve outcomes for patients living with brain cancer, which will not only benefit patients but also encourage more investments into the firm, which will boost its growth.

Candel Therapeutics (CADL), closed Saturday's trading session at $1.8, up 21.6216%, on 327,899 volume. The average volume for the last 3 months is 5,908 and the stock's 52-week low/high is $1.48/$11.98.

Socket Mobile (SCKT)

QualityStocks, TradersPro, StockOodles, The Bowser Report, MarketClub Analysis, InvestorPlace, MarketBeat, DrStockPick, BestOtc, CRWEWallStreet, PennyToBuck, CRWEFinance, PennyOmega, BUYINS.NET, StockHotTips, StockMarketWatch, StreetInsider, CRWEPicks, Broad Street, FeedBlitz, Marketbeat.com, PennyStocks24, PennyTrader Publisher, Schaeffer's, SmallCapVoice, The Street and OTCBB Journal reported earlier on Socket Mobile (SCKT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Socket Mobile Inc. (NASDAQ: SCKT) (FRA: SNB1) is a mobile data capture firm that is engaged in the provision of data capture and delivery solutions.

The firm has its headquarters in Newark, California and was incorporated in March 1992 by Charlie Bass and Michael L. Gifford. Prior to its name change in April 2008, the firm was known as Socket Communications Inc. It operates as part of the computer hardware industry, under the technology sector. The firm serves consumers around the globe, with a focus on consumers in Europe, the United States and Asia.

The enterprise’s offerings include software developer kits to application developers which allow them to offer their users advanced bar-code scanning features; and cordless data capture devices which connect over Bluetooth and work with applications running on computers, smartphones and tablets. Its cordless data capture devices include the DuraScan 700 series, which is comprised of D745, D740, D755, D750, and D760 universal bar-code scanners which read all common 1D, 2D,stacked and postal codes; the D730 1D laser bar-code scanner; and the D700 1D linear imaging scanner. The enterprise’s products are incorporated into mobile applications used in point of sale, asset tracking, mobile commercial services, transportation and logistics, manufacturing process and quality control, education, medical and event management.

The company recently launched a new line of linear bar-code and QR code readers, comprising of SocketScan S820, DuraSled DS820 and DuraScan D820. These new models will not only offer a different level of versatility and transparency to its users but also bring in additional revenues into the company.

Socket Mobile (SCKT), closed Saturday's trading session at $2.1, even for the day, on 5,911 volume. The average volume for the last 3 months is 988,444 and the stock's 52-week low/high is $1.98/$9.30.

Proterra Inc. (PTRA)

QualityStocks, MarketBeat, InvestorPlace, MarketClub Analysis, Stock Preacher, SuperStockTips, Beacon Equity Research, Trade of the Week, Schaeffer's, InvestorSoup, Daily Trade Alert, Dividend Opportunities, Insider Wealth Alert, Investopedia, Barchart, NBT Equities Research, Penny Stock Craze, Penny Stock Finder, Penny Stocks Finder and Investors Alley reported earlier on Proterra Inc. (PTRA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Proterra Inc. (NASDAQ: PTRA) (FRA: 6VL) (BMV: PTRA) is an automotive and energy storage firm that is engaged in the provision of commercial vehicles.

The firm has its headquarters in Burlingame, California and was incorporated in July 2004. It operates as part of the auto manufacturers industry, under the consumer cyclical sector. The firm serves consumers around the globe, with a primary focus on consumers in Japan, Australia, Canada, the European Union and the United States.

The company is focused on providing end-to-end solutions that enable commercial vehicle electrification, through its electric vehicle technology. Its objective is to help eliminate fossil fuel dependency and decrease costs.

The enterprise operates through the Proterra Transit, Proterra Powered and the Proterra Powered Energy business units. Its Powered and Energy business units are involved in designing, developing, manufacturing, selling and integration of battery systems and electrification solutions into vehicles for commercial vehicle original equipment manufacturer customers serving school buses, delivery trucks, construction and mining equipment, coach buses and other applications. It also offers turnkey fleet-scale, high-power charging solutions and software services. On the other hand, its Transit business designs, manufactures and sells electric transit buses as an original equipment manufacturer for North American public transit agencies, universities, airports and other commercial transit fleets.

The firm recently entered into a new collaboration to power Eldorado National’s second-generation electric transit buses with its battery technology. This move will not only bring in additional revenues into the firm and open it up to new growth opportunities but also reduce air pollution through zero-emission transportation.

Proterra Inc. (PTRA), closed Saturday's trading session at $5.1, up 0.196464%, on 988,444 volume. The average volume for the last 3 months is 76,519 and the stock's 52-week low/high is $4.26/$13.22.

Lantronix (LTRX)

TraderPower, MarketBeat, TradersPro, SmarTrend Newsletters, Wall Street Resources, QualityStocks, StreetInsider, StockMarketWatch, StockRockandRoll, StockOodles, Zacks, InvestorPlace, The Street, Greenbackers, TopPennyStockMovers, PennyStockLocks.com, PennyStockLocks, Penny Stock 101, Marketbeat.com, Wealth Insider Alert, Journal Transcript and SeeThruEquity Research reported earlier on Lantronix (LTRX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Lantronix Inc. (NASDAQ: LTRX) is a networking firm that is engaged in the provision of solutions for traffic management, video surveillance, infotainment systems, edge computing, robotics and remote environment management.

The firm has its headquarters in Irvine, California and was incorporated in June 1989 by Bernhard Bruscha. It operates as part of the communication equipment industry, under the technology sector. The firm serves consumers in Japan, Africa, the Asia Pacific, the Middle East, Europe and the Americas.

The enterprise’s products include Embedded IoT Modules, including application processing delivering computations to meet customer needs for computer vision, data transformation, machine learning, audio/video aggregation and distribution, augmented/virtual reality and custom applications; and IoT System Solutions, which offer wired and wireless connections that improve the utility and value of modern electronic systems and equipment through secure network connectivity, application hosting, power for IoT end devices through Power over Ethernet, media conversion, protocol conversion, secure access for distributed IoT deployments and various other functions. It also provides telematics devices, which offer power efficient products designed to support communications across interfaces and industrial protocols for fleet, vehicle and asset tracking and management; and services for software, hardware and mechanical engineering for audio, camera and artificial intelligence/machine learning development.

The company recently acquired Uplogix, a management solutions provider. This acquisition will not only solidify the company’s market position with complementary high-end solutions but also increase its product offerings. This will, in turn, generate additional revenues as well as extend its consumer reach, which will positively influence the company’s overall growth.

Lantronix (LTRX), closed Saturday's trading session at $4.56, up 0.21978%, on 76,519 volume. The average volume for the last 3 months is 228,981 and the stock's 52-week low/high is $4.33/$10.25.

Instil Bio (TIL)

Louis Navellier and MarketBeat reported earlier on Instil Bio (TIL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Instil Bio Inc. (NASDAQ: TIL) is a clinical-stage biopharmaceutical firm that is focused on the development of therapies to help treat patients with cancer.

The firm has its headquarters in Dallas, Texas and was incorporated in August 2018. Prior to its name change, the firm was known as Immetacyte. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers across the globe.

The company is focused on the development of a cell therapy pipeline of autologous tumor infiltrating lymphocytes for the treatment of cancer. Its technology platform is based on the use of tumor-infiltrating lymphocytes (TILs), which are T-cells isolated from a patient’s tumor and can detect and eliminate cancer cells.

The enterprise’s TIL product pipeline is comprised of a formulation dubbed ITIL-168, which has been developed for a range of indications, including non-small cell lung cancer, cutaneous squamous cell carcinoma, cervical cancer and head and neck squamous cell carcinoma. It is also involved in the development of ITIL-306, which can recognize folate receptor alpha (FOLR1) with indications, including non-small cell lung cancer, gynecological, renal cancer and others. The enterprise also leverages its TIL technology to treat metastatic melanoma patients.

The firm, which recently released its latest financial results, remains committed to advancing its TIL therapy pipeline. The success and approval of its therapy formulations will not only benefit patients suffering from various cancers but also boost revenues and investments into the firm. This is in addition to bolstering the firm’s overall growth.

Instil Bio (TIL), closed Saturday's trading session at $4.49, up 6.1466%, on 228,981 volume. The average volume for the last 3 months is 27,914 and the stock's 52-week low/high is $3.9001/$23.215.

Viant Technology (DSP)

MarketBeat, Trades Of The Day and Daily Trade Alert reported earlier on Viant Technology (DSP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Viant Technology Inc. (NASDAQ: DSP) is an advertising software firm that is focused on developing and managing an enterprise software platform.

The firm has its headquarters in Irvine, California and was incorporated in 2020, on October 9th by Russell T. Vanderhook, Christopher John Vanderhook and Timothy C. Vanderhook. It operates as part of the software-application industry, under the technology sector. The firm serves consumers around the globe.

The enterprise’s offerings include an enterprise software platform known as Adelphic, which allows marketers and their advertising agencies to plan, purchase and measure advertising across channels, including mobile, desktop, connected and linear TV, streaming audio, in-game and digital billboards. It also provides an omnichannel demand side platform for marketers and their agencies dubbed Holistic, which enables them to manage omnichannel campaigns and access metrics from every channel to inform decisions in other channels; and a household profile known as Viant Household ID, which offers household insights for optimized bid decisions and touchpoint collection across consumer pathways, as well as provides holistic targeting and measurement across channels. The enterprise also provides a self-service interface which offers clients transparency and control over their advertising campaigns and underlying data infrastructure, as well as onboarding data integrations which offer marketers high match rates to audience insights for segmentation, targeting and measuring outcomes.

The company, which remains focused on generating value for its shareholders, recently released results from its latest Total Economic Impact study which show that over the last 3 years, it delivered 143% return on investment to its shareholders.

Viant Technology (DSP), closed Saturday's trading session at $4.22, up 1.199%, on 32,040 volume. The average volume for the last 3 months is 10.17M and the stock's 52-week low/high is $3.8501/$13.50.

Newmont Corporation (NEM)

MarketClub Analysis, InvestorPlace, The Street, Kiplinger Today, Schaeffer's, StocksEarning, INO.com Market Report, The Online Investor, Barchart, MarketBeat, StreetAuthority Daily, Daily Trade Alert, TopStockAnalysts, StreetInsider, Top Pros' Top Picks, Louis Navellier, Streetwise Reports, Daily Wealth, SmarTrend Newsletters, Zacks, Money Morning, Uncommon Wisdom, TradingMarkets, Marketbeat.com, PROFIT CONFIDENTIAL, The Growth Stock Wire, Trades Of The Day, Wealth Daily, Investopedia, TheStockAdvisor, The Wealth Report, Lebed.biz, ProfitableTrading, Wall Street Grand, Cabot Wealth, Investing Signal, The Best Newsletters, TheStockAdvisors, Market Intelligence Center Alert, Dividend Opportunities, Trading Markets, National Inflation Association, QualityStocks, All about trends, Market FN, InvestmentHouse, Energy and Capital, Wyatt Investment Research, Money and Markets, AllPennyStocks, Stockhouse, Darwin Investing Network, InvestorsObserver Team, TradingAuthority Daily, OTC Stock Pick, Buttonwood Research, Street Insider, Wall Street Daily, Daily Markets, Dynamic Wealth Report, The Tycoon Report, StreetAlerts, Investors Alley, Wall Street Greek, Investiv, Market Authority, Trading Concepts, Trader Jack, Investment House, Wealth Insider Alert, Investing Futures, 24/7 Trader, Short Term Wealth, Investment U, Daily Profit, The Stock Enthusiast, StockTwits, FNNO Newsletters, MarketWatch, FutureMoneyTrends.com and Penny Stock Buzz reported earlier on Newmont Corporation (NEM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Since this year began, we have seen a correction in the price of gold corresponding to the increasing rates of interest/bond yields. Gold has also been beat by the strengthening U.S. dollar, highlighting its negative correlation to the price of gold.

We have also seen the price of spot gold drop to its current $1,666.45 from the $1,801.40 recorded at the start of 2022. Last month, gold dropped to its lowest level since 2020, driven by expectations of an increase in interest rates by the Fed. Thus far, the Federal Reserve has raised rates of interest five times in an effort to combat high inflation. It is expected that when the Federal Open Market Committee meets next month, interest rates will increase again.

Investors interested in gold have been cautioned that the precious metal’s market may continue struggling to the year’s end as higher rates of interest support the U.S. dollar. In a recent report, Heraeus Precious Metals’ commodity analysts stated that the dollar’s strength would continue to depress the price of gold, as long as the Federal Reserve continued on its present path.

Experts believe that the markets will not see any pivot until the end of next year. Despite this, there are new trends that point to light at the end of the tunnel for this valuable precious metal. Those trends include a shift in gold-purchasing from Western to Eastern/Asian markets and investors ditching U.S. Treasuries. Experts also believe that we are at the point in the metal’s cycle right before gold turns upward.

Recent data shows that gold has actually performed well this year, having outperformed foreign and U.S. bonds, foreign stocks, the S&P 500, the NASDAQ and U.S. Treasury Inflation-Protected Securities. Only the U.S. dollar, oil commodities and agricultural goods outperformed the precious metal.

Rising bond yields show that investors believe that the Federal Reserve will take whatever measures it can to reduce inflation and will triumph without crashing the economy. However, if the Federal Reserve cannot control inflation due to the weakened state of the economy, it will revert back to loose monetary policies, which will positively influence gold’s performance.

Additionally, with geopolitical and recessionary risks increasing, we may see investors employ the use of more defensive strategies, making use of quality assets such as gold to help decrease losses in their portfolios. This will encourage the demand for this precious metal as an investment hedge for the long term, just as it will have a beneficial effect on the stocks of entities such as Newmont Corporation (NYSE: NEM) (TSX: NGT).

Newmont Corporation (NEM), closed Saturday's trading session at $42.37, up 2.9898%, on 10,170,429 volume. The average volume for the last 3 months is 340,732 and the stock's 52-week low/high is $40.00/$86.37.

The QualityStocks Company Corner

Flora Growth Corp. (NASDAQ: FLGC)

The QualityStocks Daily Newsletter would like to spotlight Flora Growth Corp. (NASDAQ: FLGC).

Senator Cory Booker has revealed that there is a chance that some marijuana policy reforms, such as social justice and cannabis banking reforms, can still be approved by Congress during the session coming just after the November elections and before a new House takes office. He was quick to add that such an opportunity may be harder to get in case Republicans wrest control of either the House of Representatives or Senate out of the control of the Democrats. The senator made these remarks during an interview with a New Jersey-based media outlet called NJ.com. Booker said that Congressional leadership was conducting active negotiations regarding a series of marijuana policy change proposals before the recess paving way for midterm elections starts. Booker was confident that during the sittings, often called lame-duck sessions, there is a high possibility that bipartisan support will galvanize into action in favor of passing reform before a new Congress takes office. This is because supporters on both sides of the political aisle are aware that passing cannabis reforms is likely to become harder once the elections bring changes to the dominant party in either legislative chamber. The cannabis industry and entities such as Flora Growth Corp. (NASDAQ: FLGC) await any changes that may come out of Capitol Hill during the lame-duck session and beyond. Hopefully, those changes bring the long-awaited policy reforms that can enable the industry to grow while addressing concerns about public health and access by minors.

Flora Growth Corp. (NASDAQ: FLGC) is an internationally focused cannabis brand builder that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions, including cosmetics, hemp textiles, and food and beverage. Flora Growth operates one of the largest outdoor cultivation facilities in the world with an aim of marketing a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, the company creates premium products that help consumers restore and thrive.

Flora Growth completed the first traditional cannabis IPO on Nasdaq in May 2021. Although currently headquartered in Toronto, Ontario, with plans to relocate its head office to Miami, Florida, the company’s base of operations is in Colombia, where it has built an extensive distribution network that includes Colombia’s largest distributors.

Currently, Flora Growth is organically growing market share for its existing brand portfolio (pharmaceuticals, textiles, cosmetics, and food & beverage) while seeking revenue-generating acquisitions that offer an accretive distribution network to amplify revenue growth.

Existing Brand & Product Portfolio

Flora Growth’s portfolio spans a number of verticals – each with a thoughtful brand designed to resonate with its intended end consumer. In line with the company’s mission, each brand prioritizes natural ingredients and value-chain sustainability.

Flora Lab S.A.S

Flora Lab is the company’s GMP certified manufacturing and R&D center focused on producing pharmaceuticals, cosmetics, and nutraceuticals for domestic and international markets. Its offerings include product lines that are private label, white-label, and custom formulas.

Through Flora Lab, Flora Growth has relationships with 1,500+ distribution channels, manufactures 63+ OTC products registered with INVIMA (Colombia National Food and Drug Surveillance Institute), and holds multiple GMP certifications enabling international export in an effort to leverage Flora Lab’s capacity to produce a wide range of CBD-infused products.

Flora Beauty

Flora Beauty is the company’s CBD beauty and cosmetics division founded by fashion and beauty industry icon Paulina Vega. Its current offerings include two CBD skincare brands targeting the U.S. and Latin American markets – MIND NATURALS and AWE. These lines exemplify Flora Growth’s socially conscious approach to business.

Currently, Flora Beauty products are offered globally through e-commerce, as well as through Falabella’s 111 retail locations across Latin America. The company is in negotiations with major department stores to launch the line in the U.S. and is also exploring opportunities in the U.K. and other European markets.

KASA Wholefoods

KASA Wholefoods is a Colombian manufacturer of food and beverages leveraging responsibly sourced exotic fruits from the Amazon. KASA has a $10 million+ distribution agreement with Tropi, Colombia’s largest food distributor, which has 130,000+ distribution points across the country.

Mambe, KASA’s leading brand, is already offered through over 980 distribution points across Colombia. Flora Growth expects this network to grow to over 1,200 distribution points in 2021, including one of Colombia’s largest coffee chains, Tostao Café & Pan.

Hemp Textiles & Co.

Through its Hemp Textiles division, Flora Growth intends to utilize its large land package and cultivation infrastructure to capture market share in the rapidly growing hemp industrials segment.

The company’s first brand through this division, Stardog Loungewear, offers a line of comfortable loungewear made from natural, organic materials. Stardog has been distributing globally through e-commerce and brick and mortar channels in Bogota since fall 2020, and the company intends to open U.S. brick and mortar locations in 2021.

Accretive M&A

Flora Growth is targeting transactions to complete the supply chain via key infrastructure to enhance its global distribution with the aim to compete on low-cost, high-quality inputs paired with premium brands that create business lines with robust margins.

To date, Flora has announced two major transactions.

Koch & Gsell (Acquisition)

  • Amplify CPG portfolio’s revenue growth through leading brand, Heimat, currently with TTM revenues of $7.6 million.
  • Leverage Koch &Gsell’s distribution network of 2,500+ stores to introduce Flora to the Swiss, European and Asian markets.
  • Bring patented hemp cigarette manufacturing technology into new markets utilizing Flora’s high-quality cannabis.

Hoshi International (Investment)

  • Equity Investment of €2 million into Hoshi to establish Flora as a preferred supplier to two EU processing facilities.
  • Opens gateway for Flora Growth’s cannabis through international distribution agreements in the EU and U.K.
  • Hoshi’s experienced team and increased access to the EU cannabis market to serve as a catalyst for revenue growth.

Cultivation

Key to Flora Growth’s expansion efforts is its cultivation strategy. The company’s Cosechemos farm, located in Bucaramanga, Colombia, is currently licensed to cultivate 247 acres of cannabis. Through three successful pilot crop plantings, the location has demonstrated a production cost of just $0.06/gram. For comparison, the average cost of North American cannabis (based on 2019 figures from Aphria, Tilray, Sundial, and Aurora) equates to roughly $1.89/gram.
Flora Growth is uniquely positioned to capitalize on Colombia’s favorable growing conditions, low-cost infrastructure, and affordable local workforce as it looks to ramp up its cultivation efforts moving forward.

Leadership Team

Bernard Wilson is the Chairman of Flora Growth. A senior financial professional, Dr. Wilson is the former Vice-Chairman of PricewaterhouseCoopers LLP and is the Chairman of the Founders Board of the Institute of Corporate Directors. He has also served as Chairman of the Canadian Chamber of Commerce; Chairman of the International Chamber of Commerce – Canada; and Member of the Canada/U.S. Trade Committee. Dr. Wilson draws on this experience to ensure Flora Growth adheres to effective corporate governance practices.

Luis Merchan is the company’s President and CEO. He is a proven executive with over a decade of experience in enterprise sales management, corporate strategy, merchandising and expense management, and customer experience. Mr. Merchan previously served as Macy’s Inc.’s Vice President of Workforce Strategy and Operations, where he managed the enterprise’s multi-billion-dollar P&L expense line for the entire 540 store portfolio. Throughout his tenure at Macy’s, he led various sales and marketing initiatives, including the B2B corporate sales team that was responsible for $160 million in annual revenue. Mr. Merchan obtained his Bachelor of Industrial Engineering from Pontifical Xaverian University in Bogota, Colombia, and his MBA from McNeese State University. He also holds a Graduate Certificate in Marketing Management from Harvard.

Juan Manuel Galan is a Strategic Advisor to the Flora Growth management team. Mr. Galan currently serves as a senior consultant to The World Bank. He is a politician and former senator of Colombia, serving three terms from 2006 to 2018 as a member of the Colombian Liberal Party. He is also a former professor at the University of Rosario and holds more than 20 years of journalistic, academic, governmental and parliamentary experience. During his time as a senator, Mr. Galan was a key leader, with 29 bills and 27 debates on political control, and 17 laws to his name. The most relevant of those laws was authoring the medical cannabis law that resulted in the legalization of medical cannabis in Colombia.

Stan Bharti is a Director of Flora Growth. Mr. Bharti currently serves as Executive Chairman of Forbes & Manhattan. He has more than 30 years of professional experience in business, finance, markets, operations and more, with a focus on the resource and technology sectors. To date, Mr. Bharti has amassed over $3 billion worth of investment capital for the companies with which he has worked and their shareholders. He is a Professional Mining Engineer and holds a master’s degree in engineering from Moscow, Russia, and University of London, England.

Javier Franco is the company’s VP of Agriculture. Mr. Franco is a master horticulturist with more than 25 years of experience in the design, implementation, and management of cultivation and propagation facilities of more than 30 species of cut flowers in Latin America. He completed his agricultural studies at Zamorano University in Honduras and later at an International Exchange Program at Ohio State University. Mr. Franco has directed technical, commercial, and research groups in the cut flower, fruit and vegetable markets in Latin America and has participated in the commercial development of new technologies applied in agribusiness. He has also led the agri-management of organic crops and certifications of Good Agricultural Practices.

Flora Growth Corp. (FLGC), closed Saturday's trading session at $0.5391, up 3.6531%, on 341,882 volume. The average volume for the last 3 months is 203,600 and the stock's 52-week low/high is $0.5011/$5.6092.

Recent News

Cerberus Cyber Sentinel Corp. (NASDAQ: CISO)

The QualityStocks Daily Newsletter would like to spotlight Cerberus Cyber Sentinel Corp. (NASDAQ: CISO).

Cerberus Sentinel (NASDAQ: CISO) , an industry leader as a managed cybersecurity and compliance provider based in Scottsdale, Arizona, was featured in a recent equity research report published by Cantor Fitzgerald titled “Strong Vision and M&A Execution Playbook Position to Address Cyberattacks, Cybersecurity Talent Shortages; Launching Coverage at OW with a $5 PT.” The publication reads, “Growth Strategy Focused on Acquisitions and Organic Expansion. Cerberus Sentinel intends to capitalize on the growing ‘achievement gap’ between increased risk and exposure to cyber threats and the decreasing pool of resources available to address this risk as its core growth opportunity. The majority of the company’s revenue is generated from managed services and, to a lesser extent, professional services. We believe CISO has built a strong, repeatable acquisition strategy aimed at engineer-operated cybersecurity firms in the $2-25 million revenue range with each deal expected to be accretive. We believe these up/cross-sell opportunities should drive sustainable organic growth in the 15-20% range with broaden service offerings upholding the organic cross-sell funnel.” To view the full report, visit https://ibn.fm/uY8wT

Cerberus Cyber Sentinel Corp. (NASDAQ: CISO) is an industry leader in cybersecurity and compliance services. The company leverages an integrated approach to reduce noise and bridge common silos that often limit the effectiveness of cybersecurity programs. Pulling disparate technologies, teams, and vendors together, Cerberus helps its clients enjoy a simpler and more successful journey to cyber resilience. Since 2019, Cerberus Sentinel has worked to rapidly expand by acquiring world-class cybersecurity and compliance businesses with top-tier talent who utilize the latest technology to create innovative protection solutions.

The Cerberus Sentinel workforce is comprised of cybersecurity experts spanning not only global geographies, but also specialties, industries, regulatory frameworks and focus areas. Its team includes audit and compliance specialists, certified forensics experts, ethical hackers, IEEE® certified biometric professionals, security engineers, around-the-clock analysts, and more – all backed by the most respected credentials in the industry. On an ongoing basis, the company works to identify cyber talent that is culturally aligned and that offers operating leverage through both existing customer revenue and relationships.

Cerberus Sentinel has invested in enterprise solutions and executive talent to integrate its different organizations into an ecosystem that works together to provide complete cybersecurity through cross-pollination of solutions that begin at the network level and extend through technologies, people, policy, and practices. This ecosystem is intended to foster additional growth opportunities and drive overall recurring revenue. Once engaged, the company strives to become trusted advisors for customers’ cybersecurity and compliance demands by providing tailored security solutions based upon their organizational needs.

While cyber resilience requires cycles of continuous improvement, it is a journey that few in the current business and security climate seem to understand. With its deep bench of seasoned experts, Cerberus Sentinel works to simplify that journey for its growing customer base, straightening out the curves and speeding up the process to resilience along the way.

Cybersecurity is a Culture, Not a Product

Integrating compliance and security, including principles of security by design, Cerberus Sentinel helps its clients create an organization-wide culture of cybersecurity. Its offerings include audit and compliance, security operations center services, security engineering, virtual Chief Information Security Officer services, incident response, certified forensics, technical assessments and cybersecurity training.

In contrast to the majority of cybersecurity firms that specialize in a specific technology or service, Cerberus Sentinel seeks to differentiate itself by remaining technology agnostic, focusing on accumulating highly sought-after subject matter experts. Cerberus Sentinel believes that bringing together a world-class team of technological experts with multi-faceted proficiency in the critical aspects of cybersecurity is key to providing technology agnostic solutions to its clients in a business ecosystem that suffers from a chronic lack of highly skilled professionals.

Cerberus Sentinel’s goal is to create a culture of security and to help quantify, define and capture a return on investment from information technology and cybersecurity spending. Its end-to-end, holistic process covers every aspect of clients’ cybersecurity and compliance requirements in an effort to promote greater efficiency and strengthen awareness about the integral role of internal team members in the cybersecurity culture of an organization.

As a result of this strategy, Cerberus Sentinel customers receive an efficient engagement from a single partner that covers a wide range of their needs – addressing challenges more thoroughly and resolving problems more rapidly when compared to working with a host of vendors.

Market Outlook

According to an analysis by the firm Research and Markets, the global managed security services market was valued at $22.45 billion in 2020 and is projected to reach $77.01 billion by 2030, growing at a CAGR of 12.8% through the forecast period.

An expected increase in cybercrime, cost effectiveness of provided solutions and stringent mandatory government regulations aimed at protecting corporate data will drive the global managed security services market for the foreseeable future.

In addition, the documented and growing use of mobile devices in the workplace and the rise in captured and stored digital data serve to fuel market growth. Moreover, growing awareness about the critical nature of data security, the growing importance of e-business and demand for customized services is expected to offer ample opportunities for expansion of the market during the forecast period.

Management Team

David Jemmett is CEO and founder of Cerberus Sentinel. He has more than 35 years of executive management and technology experience with telecommunications, managed services, and cybersecurity consulting services. He previously held positions as CEO of GenResults, a leading provider of security consulting services and technology solutions, and as CTO and founder at ClearData Networks, a HIPAA-compliant HealthDATA cloud hosting platform.

Dave Bennett is COO at Cerberus Sentinel. Since 2015, he has served on the President’s STEM Advisory Board of Grand Canyon University. Before joining Cerberus Sentinel, he served as Chief Product Officer at Experian Health and as Senior Vice President, Product for Gainwell Technologies. He has also held positions as Vice President and Worldwide Head of Build, Healthcare and Life Sciences at DXC Technology, and as EVP, Product and Strategy at Orion Health.

Ashley Devoto is President and Chief Information Security Officer at Cerberus Sentinel. Over the past 17 years, Devoto has worked with the cybersecurity elite to design, build, and operate world-class cybersecurity programs for large, diverse organizations in both government and commercial enterprises. Prior to joining Cerberus, Devoto served as CISO for Booz Allen Hamilton, as business information security officer (BISO) at Bank of America, and as a cyberspace operations officer in the United States Air Force.

Deb Smith is CFO at Cerberus Sentinel. Prior to assuming that position, she was the company’s EVP, Finance and Accounting. She has also served as SVP, Global Accounting at International Cruise and Excursions Inc., and as Chief Accounting Officer for BeyondTrust, an information security software company. She has also held the positions of Corporate Controller at Aspect Software and Assistant Controller at JDA Software.

Cerberus Cyber Sentinel Corp. (NASDAQ: CISO), closed Saturday's trading session at $3.17, up 4.9669%, on 203,634 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $5.6092/$.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN) , an emerging electric vehicle (“EV”) manufacturer, today announced the hiring of John Schwegman as its chief commercial officer (“CCO”) for Mullen’s line of commercial vehicles. Prior to joining Mullen, Schwegman spent 35 years of his career at General Motors (“GM”), holding various executive-level roles and leading global teams across four continents. At GM, he oversaw the growth of commercial product lines, repositioned core brands, developed Chevrolet's core electric vehicle prioritization, relaunched GM’s previously retired medium-duty commercial fleet business and more. “John has tremendous experience in commercial automotive sales, and this makes him a highly strategic addition to Mullen,” said David Michery, CEO and chairman of Mullen Automotive. “We are very excited to have John on board; he will play a central role as CCO in the product planning and business development of our commercial vehicle division.” To view the full news release, visit https://ibn.fm/K0UCi . California has led the way in enacting ambitious legislation that seeks to ban the sale of internal combustion engine vehicles by 2035. One would therefore assume that any proposed law that furthers this objective would gain near-unanimous support from the governor and key advocacy groups, but this isn’t the case with regard to Proposition 30. This ballot measure wants the rich — specifically those earning at least $2 million annually — to incur an additional 1.75% tax that will go toward helping people in poorer communities access electric vehicles. Some of that money would also be directed toward combating wildfires, an occurrence that has become more severe in recent years and threatens to worsen the climate change situation due to the millions of tons of carbon released into the atmosphere as those fires rage in the state. The measure’s noble intentions notwithstanding, Governor Gavin Newsom has come out openly to oppose the ballot initiative . He says that it is a ploy by ridesharing company Lyft to have tax dollars go toward helping its drivers. Lyft has injected about $45 million into the campaign drumming up support for this initiative, which is slated to go before voters in a few weeks during the midterm elections.

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Saturday's trading session at $0.3761, up 7.3039%, on 196,419,032 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.2101/$15.90.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria Bioscience Corp. (NASDAQ: LEXX) , a drug delivery platform innovator, last year announced a review of its successful 2021 antiviral drug program. “Lexaria specifically probed the bioavailability of five DehydraTECH(TM)-processed antiviral drugs for SARS-CoV-2, HIV/AIDS and other infectious diseases from three drug classes, evidencing significant gains with up to a three-fold increase in oral drug delivery into the bloodstream. The demonstrated improvements in absorption, Lexaria believed, could have significant commercial potential considering that many antiviral drugs typically show low oral bioavailability in their available form because of significant liver biotransformation and/or poor intestinal uptake,” reads a recent article. “Lexaria’s vision for DehydraTECH is not limited to antiviral drugs as the company is also focusing on other possible mainstream applications of its disruptive drug delivery platform, including but not limited to oral nicotine and cannabidiol (‘CBD’). Pharmacokinetic studies evaluating these compounds have, in fact, shown that DehydraTECH delivers higher quantities of these APIs in less time… DehydraTECH’s ability to increase the performance of different APIs represents multiple commercial opportunities that, when tapped, could potentially address serious unmet patient needs.” To view the full article, visit https://cnw.fm/8Mnlp

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has a collaborative research agreement with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has filed for patent protection for specific delivery of nicotine, vitamins, NSAIDs, testosterone, estrogen, cannabinoids, terpenes, PDE5 inhibitors (with brand names like Viagra), tobacco and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Saturday's trading session at $2.06, even for the day, on 4,654 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.80/$6.83.

Recent News

Correlate Infrastructure Partners Inc. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Infrastructure Partners Inc. (OTCQB: CIPI).

Correlate is energizing solaxr power adoption by offering a complete suite of proprietary uniquely affordable clean energy solutions for the commercial real estate industry

It is estimated that, by 2050, the average LCOE (Levelized Cost Of Electricity) for solar PV will fall from the current $50/MWh level to around $30/MWh, with individual projects costing well below $20/MWh

This drop is representative of the trend from 2011 to 2022 that has seen an 89% drop in the cost of new technologies in solar energy, a 59% drop in onshore wind, and a 61% drop in offshore wind energy tech

Correlate is looking to take advantage of this cost drop to further deploy as many solar power installations in the United States as possible, ultimately accelerating solar power adoption and aiding the energy transition in the country

Its approach shows its commitment to consistently creating value for its shareholders and consumers

Correlate Infrastructure Partners (OTCQB: CIPI) , through its two subsidiaries, Correlate, and Solar Site Design, is looking to help accelerate solar energy adoption in the United States. By offering a complete suite of proprietary clean energy assessment and fulfillment solutions for the commercial real estate industry, the company is lowering the barrier of entry and incentivizing even more real estate owners and companies to hop onto the renewable energy space, with the promise of lowering their carbon emissions and reducing the overall cost associated with energy consumption.

Correlate Infrastructure Partners Inc. (OTCQB: CIPI), formerly Triccar Inc., through its two subsidiaries, Correlate and Solar Site Design, offers a complete suite of proprietary clean energy assessment and fulfilment solutions for the commercial real estate industry. The company believes scaling distributed clean energy solutions is critical in mitigating the effects of climate change. CIPI is at the forefront in creating an industry-leading energy solution and financing platform for the commercial and industrial sector. The company sees tremendous market opportunity in reducing site-specific energy consumption and deploying clean energy generation and energy efficiency solutions at scale.

The opportunity exists to remove friction between today’s legacy finance process and the needed clean-energy upgrades developed within the company’s program technologies. For the U.S. to reach its 2050 carbon goals, 200,000 commercial buildings must be retrofitted every year until that date. That represents approximately a 5-10x increase over the 2022 industry process run rate.

CIPI announced completion of its acquisition of 100% of the equity of Correlate Inc. and Loyal Enterprises LLC dba Solar Site Design on December 28, 2021. The company notes these acquisitions occurred at a key inflection point of its growth. CIPI currently enjoys channel and sales partnerships with Fortune 250 companies and a strong, proven industry network.

The company’s transparent, leading-edge model changes value delivery for both facility owners and proven solution providers seeking scale. CIPI believes its rapid growth is due to industry demand for actionable, cashflow positive energy programs and the underlying carbon reduction mandates taking effect globally.

CIPI has filed with the SEC for a name change to Correlate Infrastructure Partners Inc., which will more closely reflect its new platform and growth focus. The company has been aggressively moving to rebrand, with efforts including a revised website, investor presentation materials and an investor relations awareness campaign. The company’s shares will continue to trade on the OTCQB Venture Market under the current ‘CIPI’ ticker symbol until changes are approved.

Subsidiaries

Correlate, founded in 2015, is a portfolio-scale development and finance platform offering commercial and industrial facilities access to clean electrification solutions focused on locally-sited solar, energy storage, EV infrastructure, and intelligent efficiency measures. Its unique data-driven approach is powered by proprietary analytics, concierge subscription services, and a highly scalable national fulfillment network to help building owners profit from fully funded, turnkey decarbonization and facility health programs. The platform is designed for commercial and industrial real estate owners seeking to significantly improve net operating income while meeting carbon reduction goals. The platform provides energy programs for commercial property portfolios and requires no upfront capital. Client organizations reduce their risk and generate more profits by leveraging Correlate’s unique payment programs to put more cash in the bank. Deploying Correlate’s strategic energy programs and energy management systems allows property-owning organizations to complete big energy changes across their portfolios.

Solar Site Design, founded in 2013, is a U.S. Department of Energy Sunshot Catalyst winner that provides customer acquisition and project development tools for the commercial solar industry. Its commercial marketplace platform connects highly qualified project opportunities to leading solar construction companies nationwide. The Solar Site Design platform gives commercial and industrial property owners access to the best price for a commercial solar system. Commercial solar analysts provide property owners a site assessment and working project proposal. Solar Site Design’s team of solar engineers finalize the design while approved financing providers help clients explore financing options for their projects. Then, approved contractors in Solar Site Design’s Marketplace bid on the projects, ensuring commercial and industrial property owners get the best estimates for their projects. Solar Site Design’s marketplace process promotes transparency and fair pricing. Its team of experts has nearly 20 years of experience in the solar industry. Only reputable, experienced, certified (NABCEP), licensed, bonded and insured contractors are accepted into the Solar Site Design Marketplace.

Market Outlook

CIPI is in a rapidly growing market with a unique offering to address a total market of more than 5.9 million commercial buildings in the United States, according to the U.S. Energy Information Administration. Currently, the company’s wholly owned subsidiaries, Correlate and the Solar Site Design, have an opportunity pipeline of over $100 million in commercial projects with more than $20 million in awarded backlog. According to the Rocky Mountain Institute, portfolio energy optimization is a $290 billion market in the United States driving deep financial savings and energy efficiency across the commercial sector.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon, and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings. Yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which has very different needs than traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue known as the “split incentive”, unlocking the majority of the addressable market.

Management Team

CIPI has in place a nationally recognized management team that has been active in the energy market since 2005.

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

David Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jason Loyet is VP of Commercial Sales of Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Deke Welling is Head of Project Development and Fulfillment Services at Correlate Inc. He has over 19 years’ experience in the energy industry with an emphasis on renewables and energy efficiency over the past seven years. Prior to entering the renewables sector, Mr. Welling was the CEO of Welling Resources, an energy development company focused on the exploration of oil and natural gas reserves in the U.S. It was this experience that led him into the renewables sector and leading a charge for more sustainable resources. Additionally, Mr. Welling also served as the CEO of Circle L Solar Inc., a top 100 solar installer in the United States since 2016. Through his leadership, Circle L Solar experienced a growth rate of over 2,250% from 2016 to 2019, resulting in his company being listed on the Inc. 5000 list of the fastest growing private companies in the U.S. (Rank #176) and being named ‘Top Energy Company’ and ‘Entrepreneur of Year for the Energy Industry’ by the American Business Awards® in 2019 and again for ‘Entrepreneur of the Year’ in 2021.

Kevin Warren is Head of Construction and Development Engineering at Correlate Inc. He is a solar veteran with over 12 years of experience in the field. Prior to co-founding CLS, Mr. Warren was the owner of Beacon Consulting and has originated, consulted, designed and/or engineered over 122 MW of PV installations ranging from small commercial to utility scale projects throughout Texas, California, Colorado and North Carolina. He holds a Photovoltaic Technical Sales Professional Certification from the North American Board of Certified Energy Practitioners and certifications from Solar Energy International in PV Installation, PV Technical Sales, PV battery-based design, PV design and engineering, and PV operations and maintenance. Along with PV expertise, Mr. Warren is a LEED Green Building Associate, a certified building analyst from the Building Performance Institute, a Certified Renewable Energy Professional from the Association of Energy Engineers and holds a designation in High-Performance Sustainable Buildings from the BOMI Institute. He studied Electrical Engineering at the University of Texas at Arlington.

Tom Kunhardt is Director of Customer Success at Correlate. He previously held a similar position at Clean.Tech and was Corporate Trainer, Learning & Development, at NRG Energy. He has 15 years of experience in the solar and clean energy industries helping homeowners and businesses find solutions to their energy needs. He holds a bachelor’s degree from the University of Massachusetts.

Correlate Infrastructure Partners Inc. (OTCQB: CIPI), closed Saturday's trading session at $1.68, even for the day, on 5 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.32/$3.25.

Recent News

Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF)

The QualityStocks Daily Newsletter would like to spotlight Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF) .

Privacy regulations and changes in mobile apps reduce the supply of traditional data, leading to increased demand for new, fully compliant data solutions

Reklaim offers a platform that rewards consumers for granting data access, produces verified datasets that marketer’s access for a fee

Up to 30% of data being bought and sold in the market today is “dead” due to email bouncing, mobile ID deprecation, “Do Not Call” lists, and blacklisted IPs

Reklaim’s solutions reverse the “bad data” trend with verified information consumers actively choose to share

Market increase for data platforms is expected to increase from $1.42 billion in 2022 to $6.94 billion in 2029 at a CAGR of 25.4%

The days when companies collected consumer data and sold it to advertisers without their consent are rapidly ending as privacy regulations expand worldwide ( https://ibn.fm/1EIxu ). In addition, tech companies are taking action to reduce data mining by mobile applications ( https://ibn.fm/4aqS2 ) drastically. At the same time, advertisers still need data to fuel marketing strategies, leading to a growing demand for fully compliant consumer data solutions. Reklaim (TSX.V: MYID) (OTCQB: MYIDF) addresses that demand with a privacy-compliant identity ecosystem that gives consumers options to earn from their data while providing new datasets to brands and advertisers.

Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF) offers a privacy-compliant identity ecosystem both online (www.ReklaimYours.com) and via a mobile app on iOS and Android in the U.S and Canada. Reklaim believes that consumers own their data and, consequently, have the right to access their online data and choose how it is used, whether for compensation or privacy. Reklaim gives consumers visibility regarding how their data is collected and compensates them for its use, all while also providing advertisers and brands with a source of data compliant with emerging privacy regulations.

The company is driven by the evolution of privacy and how it impacts consumers and companies. Reklaim sells compliant, zero-party data to Fortune 500 brands, platforms, and data companies so that they can offset the risk of non-compliance. ‘Zero-party data’ is data that a consumer proactively and intentionally shares with an organization. This contrasts with ‘third-party data,’ which organizations have collected unbeknownst to consumers for more than 20 years. Zero-party data is the most valuable data in the US$200B data market, as it provides organizations with explicit consumer opt-in vs. through an intermediary such as a data broker.

Reklaim empowers consumers to take back control of their data. The company allows consumers to visit the platform, confirm their identity, and uncover their data that has been collected and sold for years without their explicit consent. Consumers can add, edit or delete data that is associated with their profile and choose which pieces of data they would be willing to share for weekly compensation. Reklaim is the only company in the world today providing consumers with both access to their data that is circulating in the market and a guaranteed weekly paycheck. Alternatively, for users who do not want to sell their data, users can choose to protect their data and subscribe to a suite of subscription-based (SaaS) privacy tools that obfuscate the location of their device when browsing on a mobile phone and alert them when a third-party source has leaked their data or passwords.

Reklaim was founded in 2018 and is based in New York, with offices in Toronto.

Business Model

Reklaim’s primary revenue-generating operations stem from selling consented consumer data to companies and resellers that need data that is compliant with all applicable consumer privacy laws and regulations, including the California Consumer Privacy Act (CCPA). Major Fortune 500 customers and enterprise data platforms have validated Reklaim’s zero-party data and have added this data to their marketplaces and decision-making. Reklaim has sales across three core verticals: brands and agencies that buy advertising, platforms that sell data to Fortune 500 clients, and companies whose primary business is selling data to business customers.

  • Companies & Agencies that Buy Advertising – These customers use Reklaim’s compliant data to inform their media decisions in social, connected television, programmatic and other verticals. Sales cycles are short at about 30 days. Reklaim customers in this segment are Microsoft, Amgen, Bayer, UPS, and Hasbro, to name a few.
  • Platforms that Sell Data – Reklaim has integrated its zero-party data into 15 of the largest enterprise data platforms in the world. These platforms act as the ‘grocery stores’ of data, where the Fortune 500 come to make their data purchases. Reklaim’s data has been validated and added to these platforms, providing ubiquitous distribution of Reklaim data across the data ecosystem. Due to data quality verification and technical requirements, sales cycles are typically longer, about 60-90 days. Customers include LiveRamp, Transunion, Google, The Trade Desk, Lotame, and T-Mobile.
  • Data Companies that Sell Data – These customers need to purchase compliant data to continue offering data to their clients. Sales cycles often last 90-120 days, but these contracts are typically annual, have the highest value, and auto-renew. An example is Nielsen, the television measurement company.

Market Outlook

The data industry, valued at $245 billion in the U.S. and more than $400 billion globally, is being disrupted, and Reklaim is positioned to benefit from the destructive shift.

The disruption is driven by two factors: (1) technology is reducing access to core data that the industry has become dependent upon, and (2) government intervention is emerging through laws and regulations intended to protect consumer data privacy.

Over the past 20 years, the data industry has harvested and exploited consumer data without consumers’ express consent. However, the legal and regulatory environment surrounding consumer data acquisition is rapidly evolving, placing the consumer at the center of emerging privacy policies.

The European Union’s General Data Protection Regulation (GDPR) was rolled out in 2019, followed shortly by the CCPA and the California Privacy Rights Act. More recently, the Canadian Privacy Protection Act, Brazil’s General Data Protection Law, India’s Information Technology Act, and South Africa’s Protection of Personal Information have continued the trend. As a result, industries and companies currently relying on unconsented consumer data will experience a regulation-driven disruptive migration, forcing them sooner rather than later to use only fully consented data sources. This consumer data environment is driving companies to Reklaim to replace their current data providers.

While privacy policies continue to iterate to include the consumer, Big Tech, namely Apple and Google, are increasingly removing data from the market that brands and companies have relied on. Apple’s introduction of Advanced Ad Tracing (ATT) has impacted companies’ ability to track consumer behavior across applications. Facebook, in Q4 2021, was forced to accept a US$10B write down on revenue projections due to this change and is expecting a similar US$10B right down again in 2022.

Google is making similar changes, the most significant being the removal of the third-party cookie from its Chrome browser, which has a 65% market share. This third-party cookie is responsible for the tracking that websites use to monetize by tracking consumers. The removal of the Chrome cookie will put the 1.8 billion websites operating in the open web today under pressure to find a solution to replace the 65% loss in revenue.

Management Team

Neil Sweeney is Chairman and CEO of Reklaim. He has more than 20 years in the industry, with an established reputation for visionary entrepreneurship and an ability to develop technologies. Technologies Sweeney created are used by Fortune 500 brands like Coca-Cola, Lowe’s, Walmart, General Motors, Unilever, and Mondelez. They are the core component of top media demand-side platforms, including Adelphic, The Trade Desk, AppNexus, MediaMath, and Triton Media. He is a two-time finalist for Ernst & Young’s ‘Entrepreneur of the Year’ and received Deloitte’s ‘Fast 50’ award for three consecutive years for the growth of organizations he created.

Ira Levy is CFO at Reklaim. He has over 15 years of experience in a wide range of high-growth, early-stage public and private companies. Most recently, he held the roles of Corporate Controller at VIVO Cannabis Inc. (TSX: VIVO) and Senior VP/Head of Finance for start-up Honest Inc. (d/b/a Province Brands of Canada). He has also acted as an advisor for startup AI companies through the Creative Destruction Lab Program. He received his MBA in Accounting and Finance from the Schulich School of Business at York University and is a Chartered Professional Accountant.

Jake Phillips is Chief Technical Officer at Reklaim. He is a proven technology leader who excels at bridging the gap between innovation and business in dynamic environments. He has gained a breadth of industry knowledge across telco/cable, banking, and client services. His professional experience spans enterprise integration, mobility, big data, cloud operations, and data security.

Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF), closed Saturday's trading session at $0.04485, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0387/$0.3859.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum Inc. (NYSE: QBTS) , a leader in quantum computing systems, software and services, and the only quantum computing company building both annealing and gate-model quantum computers, has launched in AWS Marketplace. The first and only pure-play quantum computing company with offerings available in AWS Marketplace, D-Wave’s offerings will include the Leap(TM) quantum cloud service, which offers real-time access to D-Wave’s state-of-the-art quantum computers as well as a quantum-classical hybrid solver service that can process problems with up to one million variables and 100,000 constraints.

D-Wave’s AWS Marketplace listings also include: Quantum Proof of Concept, which enables users to validate a selected quantum use case through problem discovery, problem definition, development of an initial prototype solution and testing with representative application data; Quantum Feature Selection for Machine Learning, which focuses on utilizing quantum hybrid approaches to optimize feature selection in model training and prediction; and Quantum Consulting Services, which combines technical enablement, products and services.

“The era of commercial quantum computing is here,” said D-Wave Quantum senior vice president of growth Mark Snedeker in the press release. “Forward-looking organizations are increasingly turning to quantum computing to find solutions for today’s complex and computationally intensive business problems, ultimately to reduce costs and increase revenue. By launching in AWS Marketplace, we’re introducing our Leap quantum computing service to AWS customers, enabling them to quickly and easily start deriving business value from quantum computing, today.”

To view the full press release, visit https://ibn.fm/Hsfi6

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Saturday's trading session at $4.8, off by 9.9437%, on 394,722 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $4.68/$13.23.

Recent News

Aditxt Inc. (NASDAQ: ADTX)

The QualityStocks Daily Newsletter would like to spotlight Aditxt Inc. (NASDAQ: ADTX).

Scientists from University of Texas Southwestern Medical Center, Dallas, and Andover, Massachusetts and TransMedics have discovered that there are transplanted livers that have a cumulative age exceeding one hundred years. The team of scientists studied those livers in order to find out why they were so resilient. They presented their discoveries at the 2022 Scientific Forum of the American College of Surgeons Clinical Congress. For their research, the scientists used the UNOS STAR file to locate livers that had a cumulative age equal to or exceeding one hundred years. They discovered that of the total number of livers transplanted in the period between 1990 and 2022, 25 livers were centurion livers. Centurion livers are livers with a cumulative age exceeding one hundred years. The lead author of the study, Yash Kadakia, stated that the group examined the age of every donor in addition to how long their liver survived in the person who received it. They then differentiated these livers by identifying recipient factors, donor factors and transplant factors, which helped create the combination that allowed the liver to survive to one hundred years. With various industry players such as Aditxt Inc. (NASDAQ: ADTX) working to reduce rates of organ transplant rejection, the prevalence of centurion livers is likely to gradually increase as the years roll by.

Aditxt Inc. (NASDAQ: ADTX) is a biotech innovation company developing technologies focused on mapping and reprogramming the immune system. Aditxt’s immune mapping technologies are designed to provide a personalized immune profile. Aditxt’s immune reprogramming technologies, currently preclinical, are being developed to retrain the immune system to induce tolerance to address rejection of transplanted organs, autoimmune diseases, and allergies.

As further discussed below, the company’s first commercial product is an immune mapping technology, AditxtScore™, which is designed to provide a personalized profile of the immune system.

The company’s preclinical immune reprogramming technology, Apoptotic DNA Immunotherapy™ (“ADi™”), aims to retrain the immune system to induce tolerance, with the goal of addressing vast unmet needs in transplanted organ rejection, autoimmune diseases, and allergies. The company is developing specific ADi™ products for psoriasis, type 1 diabetes, and skin grafting.

Headquartered in Richmond, Virginia, Aditxt also operates locations in Silicon Valley and New York.

AditxtScore™

AditxtScore™ is a proprietary platform designed to provide a personalized, comprehensive profile of an individual’s immune system. The underlying technology, licensed from Stanford University through an exclusive worldwide agreement, offers a highly sensitive and accurate method of detecting and quantifying cellular responses, allowing greater specificity, quantification, and amplification of both clinical and commercial opportunities.

The company’s first commercial application of the platform, AditxtScore™ for COVID-19, delivers timely reports on vulnerability and immune status relating to SARS-CoV-2 and its known variants, giving consumers and physicians the data needed to make informed health decisions. Potential future applications will offer early detection of an array of conditions, including diabetes, cardio-metabolic maladies and hormonal imbalances.

Aditxt’s AditxtScore™ immune monitoring center in Richmond, Virginia, is operational and designed to support the anticipated increased demand for AditxtScore™ as well as related products and services. The company is currently scaling its capabilities at this location, with a goal of processing up to 10 million immune system tests/reports annually.

ADi™

ADi™ is Aditxt’s immune reprogramming platform addressing disease-causing immune responses while maintaining the immune system’s ability to combat pathogenic infection. The company is commercializing a nucleic acid-based technology called Apoptotic DNA Immunotherapy™ (ADi™) which utilizes a novel approach that mimics the way our bodies naturally induce tolerance to our own tissues (therapeutically induced immune tolerance). Aditxt believes its ADi™ technology platform can be engineered to address a wide variety of indications.

Aditxt is currently developing ADi™ products for psoriasis, type 1 diabetes and skin grafting.

Currently, immuno-tolerance is achievable through chimerism and cell-based therapy, but there is a clinical need for a more practical and cost-effective approach which:

  • Can be made into a product
  • Does not require additional hospitalization
  • Is simple to produce and ship

Preclinical studies have demonstrated that ADi™ treatment significantly and substantially prolongs graft survival, in addition to successfully “reversing” other established immune-mediated inflammatory processes. ADi™ treatment is not expected to require hospitalization, instead being delivered as an injection in minute amounts into the skin.

IP Portfolio

Both AditxtScore™ and ADi™ are supported by a strong IP portfolio.

AditxtScore™, built upon initial technology invented, licensed from and used at Stanford University, is protected by U.S. patents encompassing methods, systems, and kits for detection and measurement of specific immune responses.

ADi™ technology is protected by seven patent families, including:

  • 8 U.S. patents
  • 4 pending U.S. patent applications
  • 86 foreign patents and 14 pending foreign patent applications spanning the EU, Australia, Canada, Japan, China, India and Hong Kong

These patents are broadly categorized into three groups:

  • Autoimmune diseases and Type 1 Diabetes
  • Organ transplantation and a method of producing plasmid DNA to prevent immune activation
  • Composition of matter for a tolerance delivery system for antigens of interest

Aditxt also possesses and/or in-licenses substantial know-how and trade secrets relating to the development and commercialization of its product candidates, including related manufacturing processes and technologies.

Market Overview

The potential market opportunities presented by immune monitoring and reprogramming are extensive, particularly as Aditxt continues to evaluate additional applications for the platforms.

The company’s initial focus on organ transplantation and related autoimmune response provides some insight into the potential of its approach. According to BCC Research, the global organ and tissue transplantation and alternatives market is on course to reach $120.3 billion by 2024, recording a CAGR of 7.4% from 2019. Industry data suggest that approximately 50% of all transplanted organs are rejected within 10-12 years, further highlighting the critical need for a practical, cost-effective solution to harmful autoimmune responses.

Through its focus on the COVID-19 testing market with AditxtScore™, Aditxt demonstrated the wide-ranging potential of its portfolio. Fortune Business Insights estimated the global COVID-19 diagnostics market at $48.64 billion for 2022. While demand for COVID-19 diagnostics is expected to lessen in the coming years, Aditxt will be uniquely positioned to leverage its existing infrastructure stemming from these operations as the company works to advance broader applications for the AditxtScore™ platform.

Leadership Team

Amro Albanna is the Co-Founder, Chairman, and CEO of Aditxt. He has founded multiple startups to commercialize innovations in various industries, including healthcare, enterprise software, telecommunications, nano technology, consumer health, and biotech. Mr. Albanna has led numerous M&A and going-public transactions as a founder, co-founder, and senior executive.

Shahrokh Shabahang, D.D.S., MS, Ph.D., is the company’s Co-Founder, Chief Innovation Officer, and a member of its board. He brings to the team more than 20 years of experience in developing and commercializing life science technologies focused on product and clinical development in the fields of microbiology and immunology.

Corinne Pankovcin, CPA, MBA, is the President of Aditxt. Prior to joining Aditxt, Ms. Pankovcin served as CFO for several world class organizations, including Business Development Corporation of America, Blackrock Kelso Capital and AIG Capital Partners. In these roles, Ms. Pankovcin was responsible for executing portfolio investments and managing significant M&A transactions.

Thomas Farley is the Chief Financial Officer of Aditxt. From December 2015 to June 2020, Mr. Farley was the Controller and Treasurer of Business Development Corporation of America (“BDCA”), a publicly listed business development company. Prior thereto, from January 2011 to August 2015, Mr. Farley was the Senior Controller of Blackrock Capital Investment Corporation (NASDAQ: BKCC). Prior to joining BlackRock Capital Investment Corporation, Mr. Farley was a Senior Controller for PineBridge Investments Emerging Markets practice. Mr. Farley was also an Accounting Manager for Bessemer Venture Partners prior to his tenue at PineBridge. Mr. Farley began his career with PricewaterhouseCoopers LLP, from 1996 to 2001. Mr. Farley earned his B.S. in Accounting from Long Island University and is a Certified Public Accountant.

Rowena Albanna is the company’s Chief Operating Officer. Ms. Albanna has over two decades of experience in senior leadership roles for both technology startups and public companies. Ms. Albanna’s experience spans a wide variety of industries, including biotechnology, insect control, nanotechnology, consumer electronics, financials, telecommunications, e-commerce, online marketing, medical, and defense.

Matthew Shatzkes is the Chief Legal Officer and General Counsel of Aditxt. As a former partner at an AM Law 50 law firm, Mr. Shatzkes advised a wide variety of healthcare related entities, including biotech companies, on corporate, regulatory, and strategic business matters. Mr. Shatzkes will oversee all aspects of the legal functions at Aditxt, including, providing advice and counsel on governance, regulatory matters, strategic alliances, mergers and acquisitions, and commercial transactions.


Aditxt Inc. (NASDAQ: ADTX), closed Saturday's trading session at $3, off by 2.2801%, on 3,342,700 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.58/$136.00.

Recent News

REZYFi, Inc.

The QualityStocks Daily Newsletter would like to spotlight REZYFi, Inc.

After about 50 years of legally sanctioned prohibition in the United States, marijuana has reached a pivotal moment that could rewrite the industry as it currently stands. Earlier this month, President Joe Biden directed the relevant federal agencies to conduct an exhaustive review into the scheduling of cannabis in the Controlled Substances Act. That directive has set in motion a process that could end in one of an endless list of possible outcomes , and only the most foolhardy of “analysts” can authoritatively predict what the outcome will be. For example, the review process could recommend a continuation of the status quo, that is, marijuana remains in Schedule 1 of the CSA. However, as the president himself commented, this doesn’t make sense. For instance, there is no currently documented lethal dose of marijuana because no fatality can at the moment be linked to an overconsumption of marijuana. However, the very categorization of cannabis as a Schedule 1 drug means that there will be a big mountain to climb for marijuana to be removed from this strictest categorization because cannabis research is in its relative infancy. In the highly likely event that it is removed, the big question would be: Where does it go? Schedule 2, also highly restricted but with the proviso that substances in this group can be used under medical supervision, would be the worst possible review process outcome for marijuana. As things stand, there is no telling where this review process will lead, and Biden may have unknowingly kick-started a process that could accelerate the path to marijuana legalization or make life for the existing auxiliary industry players such as REZYFi Inc. harder as more onerous federal rules affecting how companies serving the marijuana industry are required to report their dealings to federal regulators.

REZYFi, Inc. is a cannabis mortgage bank servicing the needs of both traditional and non-traditional consumers and businesses. Its target markets include licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financing and project-specific financings, such as solar installations and real estate development projects.

Headquartered in Miami, Florida, REZYFi operates through two wholly owned subsidiaries – REZYFi Lending, which primarily addresses emerging real estate-related financing opportunities, and ResMac Inc., the company’s traditional mortgage origination, correspondent and servicing operation. REZYFi is currently licensed in 34 U.S. states, with plans to expand to all remaining states later this year.

REZYFi is positioned as one of first cannabis mortgage bankers in the U.S., while most traditional lenders are still reticent to serve the state-licensed cannabis industry.

Operations

REZYFi Lending

REZYFi Lending leverages a wide network to offer options such as 15- and 30-year fixed-rate loans, FHA loans, VA loans, reverse mortgages, jumbo loans and adjustable-rate mortgages.

Looking ahead, the company expects increased funding in marketing and loan agents to drive significant origination growth over the next two years, further supported by the planned launch of a high-margin cannabis division later this year.

ResMac Inc.

ResMac has been in operation for 13 years, having closed more than 20,000 loans for more than 15,000 clients. The company expects to accumulate $285 million in retail origination in 2023, alongside $250 million in wholesale origination for the same period. ResMac is further targeting $600 million in origination through its mortgage correspondent operations for 2023.

Through its ResMac subsidiary, REZYFi operates as a direct lender and originator of residential mortgages, with active mortgage correspondent and mortgage servicing operations. Through its correspondent segment, ResMac primarily purchases and aggregates residential mortgages from trusted third-party originators.

The company intends to harvest the database of customers within its mortgage servicing operations as an essential source of additional growth, especially relative to the new alternative residential loan programs being offered.

Corporate Strengths

  • Experience – REZYFi is led by a seasoned management team with significant expertise spanning a wide range of real estate and financing subsectors. The team also has extensive experience in the cannabis and hemp marketplace, which the company intends to leverage as it navigates the changing landscape of the cannabis industry while sourcing the best opportunities in the sector.
  • Network of Independent Brokers – Over the past five years, REZYFi has developed an extensive network of independent mortgage-related brokers and licensed loan officers. The company is currently training the network members on its new service offerings, with many already launching sales efforts. REZYFi believes this network will be a vital asset moving forward as other firms in the sector terminate relationships in the face of slowing mortgage business in a rising interest rate environment.
  • Proprietary Technology – REZYFi has invested heavily in designing, building and implementing proprietary automated/machine learning technology to shorten loan processing timeframes and increase efficiencies, allowing it to operate its legacy business at staffing levels meaningfully below those of its competitors.

Market Overview

REZYFi’s diversified approach to the real estate lending sector positions it to capitalize on growth in multiple verticals in the years to come.

In the first quarter of 2022, lenders issued 2.71 million residential loans, with the average balance for a first mortgage climbing to a record high of $298,324 in 2021, according to the Mortgage Bankers Association. This trend is expected to continue, with Freddie Mac forecasting a 10.4 percent increase in home prices in 2022 and a 5.0 percent bump in 2023. Growth prospects in the cannabis industry paint a similar picture.

The National Association of Realtors® issued a report in April 2021 examining the correlation between cannabis legalization and real estate demand. In states where prescription and recreational cannabis use is legal, more than a third of surveyed agents reported an increase in demand for warehouses. Likewise, 23 percent of those surveyed reported an increase in demand for storefronts, and 28 percent observed increased demand for land. As other states look to join the 19 that have embraced full cannabis legalization, this rising demand could create an opportunity for REZYFi’s cannabis-focused initiatives.

In total, an analysis by market research firm Business Research Insights projects the global loan servicing market to reach a value of nearly $1.5 billion by 2028, up from $680.8 million in 2021. Those figures represent a CAGR of 11.0 percent during the forecast period of 2022-2028.

Management Team

John Vu, Esq., is CEO of REZYFi, Inc. He has more than two decades of experience in the mortgage and commercial banking industry. He has filled many senior and executive management positions in high-producing mortgage banks, including C-level assignments. He has also served as general counsel for a nationally associated commercial bank. Mr. Vu brings considerable cannabis industry expertise to REZYFi. He has served as a corporate attorney to multiple cannabis cultivators, manufacturers and retailers.

Ji Ji Zhang, Esq., is CFO of REZYFi, Inc. He is a multifaceted entrepreneur who owns a law firm, a portfolio of hotels and a high-producing mortgage bank. Mr. Zhang is also an investor in the development of a cannabis business park. He brings more than five years of experience in mortgage banking to REZYFi, having developed Freddie Mac and HUD licenses and amassed a managed portfolio valued at over $300 million.

Kevin Heckemeyer is President of REZYFi, Inc. He has more than 25 years of experience in mortgage banking. He has built and sold several high producing mortgage businesses. In his current roles with ResMac, he is responsible for production and operations.

Spencer Dang is Chief Credit Officer of REZYFi, Inc. He has more than a decade of experience in mortgage operations. He is a direct endorsement underwriter for HUD and has specialized in non-QM underwriting. Under his watch as an underwriter, he has never had a single repurchase.


Recent News

chart

Golden Matrix Group Inc. (NASDAQ: GMGI)

The QualityStocks Daily Newsletter would like to spotlight Golden Matrix Group Inc. (NASDAQ: GMGI).

Golden Matrix (NASDAQ: GMGI) , a developer and licensor of online gaming platforms, systems and gaming content, is leveraging the growth opportunity that has arisen as casino operators embrace digital avenues. “Golden Matrix’s GM-AG System is the industry standard for gaming platforms, including leading graphics and over 10,000 games to give casino operators a copious number of options and management software to keep customers happy and loyal to their brand. As a rule, casinos can’t have enough online table games, which is right in GMGI’s wheelhouse… Golden Matrix is only scratching the surface of the bounds of its potential domain. Most of its business has historically been business-to-business with operators focused in Asia-Pacific. Last year, the company bought 80% of RKings Competition Ltd., marking its entrance into the European markets, as well as the business-to-consumer segment. The company is amid its next expansion move, which will bring RKings’ competitions to the Mexican markets,” a recent article reads. “Because of the highly competitive nature of our industry, we are continually upgrading our systems and gaming content to support the needs of our millions of participants,” Golden Matrix CEO Anthony Brian Goodman is quoted as saying. To view the full article, visit https://ibn.fm/QtLzr

Golden Matrix Group Inc. (NASDAQ: GMGI), based in Las Vegas, Nevada, is an established gaming technology company that develops and owns online gaming IP and builds turnkey online casino solutions for gaming operators as well as configurable and scalable white-label gaming platforms for international customers, located primarily in the Asia-Pacific region. GMGI’s gaming IP includes tools for marketing, acquisition, retention and monetization of users. The company’s platform can be accessed through both desktop and mobile applications.

GMGI’s sophisticated software automatically declines any gaming or redemption requests from within the United States, in strict compliance with U.S. law.

Golden Matrix, through a subsidiary, also runs a pay-to-enter prize competition in the United Kingdom and Ireland.

The company’s shares began trading on the Nasdaq under the symbol ‘GMGI’ on March 17, 2022. Golden Matrix shares were previously traded on the OTCQX Best Market.

For the quarter ended January 31, 2022, the company reported revenue of $8.88 million, an increase of 355% over the same quarter one year earlier. Net income for the three-month period was $349,379, up from $52,158 a year earlier. It was the company’s 14th consecutive profitable quarter.

In December 2021, Golden Matrix announced it had entered into a purchase agreement to acquire a controlling ownership interest in UK-based RKingsCompetitions Ltd., one of Ireland’s and the United Kingdom’s leading independent online competition companies. RKings presents customers with paid and free entry routes to competitions that offer a range of prizes, including residential properties, luxury and exotic motor vehicles, holiday packages, technology packages and cash. The competitions are currently open only to residents of Ireland and the United Kingdom. Golden Matrix acquired an 80% ownership interest in RKings for cash and stock. The company also secured an option to purchase the remaining 20 percent interest of RKings, subject to certain requirements.

In March 2022, Golden Matrix announced it had applied for a Mexican gaming permit and, once approved, expects to offer online gaming in Mexico as well as roll out the RKings tournament business globally.

Technology

Golden Matrix Group develops fully operational online casino turnkey solutions as well as highly modular, configurable and scalable gaming platforms for its international customers in an effort to promote user acquisition, engagement, retention and monetization. The provided white label gaming platform is unparalleled in both mobile and desktop website deployment, proving compatible throughout all major operating systems and web browsers. In addition, the platform enhances the client’s ability to cater to various gaming scenarios including but not limited to transaction management and a range of loyalty and reward programs. Moreover, user engagement is optimized through the ability to accommodate both free and paid games.

The company’s GM-X System (and recently its next generation GM-Ag System) is considered the industry standard, granting access to over 10,000 games from more than 25 game providers. Through the GM-X System, Golden Matrix offers the industry’s most extensive game portfolio. The company’s gaming partners dominate the global online gaming market to deliver innovative games and premium brand titles. The GM-X System offers payment gateways that integrate with third party platforms or digital wallets. It supports all major currencies and offers multiple language options. The system’s data analytics provide the operator with a 360-degree view of the gaming platform’s performance.

GMGI currently supports over 500 unique casino brands and over 6 million players.

Market Outlook

Online gaming and sports betting sites and apps are increasingly taking market share from traditional location-based casinos. Widespread internet service availability and increasing use of mobile phones for playing online games from homes and public places is driving the market, according to a report from Grand View Research. In addition, factors such as easy access to online gambling, legalization and cultural approval, corporate sponsorships, and celebrity endorsements are also contributing to market growth. The growing availability of cost-effective mobile applications across the globe is further expected to fuel market growth.

This trend is only expected to accelerate as millennials reach their peak earning years and Gen Z youth begin to complete their education and move into careers. These generations are completely comfortable with online recreation, and with using technology like digital wallets and digital gameplay that underpins online gaming.

The global online gambling market was valued at $53.7 billion in 2019 and is expected to grow at a CAGR of 11.5% from 2020 to 2027 to reach a value of $127.3 billion, according to Grand View Research, with much of the growth expected from the U.S. and Asia. Even Europe, the most mature gaming market, is expected to grow at a rate of 20-25% year-over-year.

Management Team

Brian Goodman is CEO of Golden Matrix Group. He has more than 20 years of diverse senior management experience and business development roles within the technology and internet gaming industries. He has a tertiary science qualification as well as a marketing and sales background. His previous roles have been entrepreneurial and include CEO and senior management positions in smaller organizations, which he founded or in which he held equity, as well as multinational organizations.

Cathy Feng is COO at Golden Matrix. She is a co-founder of GMGI and holds a Master of Commerce degree. She has 10 years of experience as a financial officer in the technology and internet gaming industries. In past management positions, she interpreted, analyzed and presented financial and operation information to facilitate business decisions, grow companies and resolve complex problems. In addition, she has skills in marketing, business development, leadership and strategic planning.

Omar Jimenez is CFO and Chief Compliance Officer at GMGI. Prior to joining the company, he was CFO and COO of Alfadan Inc., a supplier of marine outboard engines. He has held senior financial management and operational positions at public and private companies including NextPlay Technologies, American Leisure Holdings, US Installation Group and Onyx Group. He holds various accounting professional certifications, including CPA and CPCU, and degrees in finance, accounting and business.

Henry Zhang is Chief Technology Officer at Golden Matrix. He oversees all aspects of development, integration and deployment of GMGI’s technology systems. He plays a key role in evolving GMGI’s technology business to lead and shape the industry. He is responsible for developing and scaling new businesses, including online gaming, eSport and P2P Systems. He was instrumental in launching the GM-X system and has been with the company for more than six years.

Golden Matrix Group Inc. (NASDAQ: GMGI), closed Saturday's trading session at $2.68, off by 2.5455%, on 24,126 volume. The average volume for the last 3 months is 24,126 and the stock's 52-week low/high is $2.51/$10.72.

Recent News

Tingo Inc. (OTCQB: TMNA)

The QualityStocks Daily Newsletter would like to spotlight Tingo Inc. (TMNA).

Binance, the top crypto exchange in the world on the basis of the volumes traded daily, has announced that it is going to make half a billion dollars available as loans to firms engaged in cryptocurrency mining. This lending program is intended to support blockchain infrastructure providers as well as Bitcoin mining entities at this time when the industry has been subjected to immense headwinds resulting in the massive loss of market value. Binance Pool said in a statement that they had an obligation to play a positive role in maintaining a blockchain and crypto ecosystem that was healthy. This initiative of making money available for borrowing by players in the crypto mining world is the first such move by Binance Pool. Through this project, Binance Pool aims at offering debt financing to BTC (blue-chip Bitcoin) firms involved in crypto mining as well as infrastructure provision. The beneficiary companies will be both publicly traded and private from all over the world. This step taken by Binance will give the industry and firms like Tingo Inc. (OTC: TMNA) a boost since it shows how confident Binance is regarding the future prospects of not just crypto mining but the blockchain industry in general. Retail and even institutional investors may therefore be strengthened in looking more favorably about the future prospects of this industry which is still in its relative infancy.

Tingo Inc. (OTCQB: TMNA) is a digital service agri-fintech technology company focused on foundation-level agriculture and related financial services in Africa. The company aims to be Africa’s leading agri-fintech player, transforming rural farming communities to connect through its proprietary platform to meet their complete needs – from inputs and agronomy to off take and marketplace – and deliver sustainable income in an impactful way. The company’s vision is to build complete digitally inclusive ecosystems that promote financial inclusion and deliver disruptive micro-finance solutions, empower societies, produce social upliftment in rural communities and open international opportunities.

Tingo believes that a truly connected world will help contribute to a better global society. The company’s core focus areas are telecoms, financial services/fintech and agritech. Tingo’s goal is to provide a best-in-class customer experience, support the domestic economies of its host countries and support technological and financial inclusion to end the poverty premium. Through this, Tingo hopes to deliver attractive returns to shareholders while investing in the long-term future of the company and its subsidiaries.

Global climate change is challenging sustainable production and food security. Tingo’s strategy and market execution provide an opportunity for Africa to be a core focal point to solve a number of key areas of concern, including food security, gender equality, financial inclusion and poverty alleviation, to name a few. Disruption of micro finance through the use of DeFi-based stable coins and smart contracts will give agri-communities access to capital markets-driven digital finance solutions that make them more competitive and sustainable economically, striking a good balance of returns between digital asset providers and Tingo as the service partner. This innovation will deliver significant access to much needed finance at ‘Grassroot’ levels, delivering tangible social upliftment and GDP growth in the African markets served by Tingo.

Tingo Mobile, with more than nine million subscribers, is Nigeria’s leading technology and device-as-a-service platform aimed at accelerating digital commerce, especially in the country’s agritech and fintech verticals. The company helps farmers acquire mobile phones through a unique leasing plan, connecting them to mobile and data networks through its own virtual mobile network. Tingo also connects farmers to markets, services and resources via Nwassa, its digital agritech marketplace platform that commenced operations in 2020. The company has also launched a beta version of TingoPay – a B2B and B2C fintech app aimed at providing financial services to users inside and outside of the agriculture value chain. Among the services offered are mobile wallets, payment processing and access to specialist lenders, insurers and pension products.

Tingo will soon announce its innovative blockchain-based solution for use of digital stable coins to empower frictionless trade across borders in Africa. The company’s market-proven model in Nigeria is its core foundation, enabling Tingo to deliver the same service model across Africa to become the continent’s leading agri-fintech business powered through smartphone technology.

The African Continental Free Trade (ACFT) plan will be a key framework to prepare the company to be the leading intra-Africa trading hub for trade flows across Africa in the medium term, when it is likely the agreement will be executed into tangible activity. Tingo is well positioned to easily transform the goals of the ACFT into reality when finally implemented by the African Union and the various African countries that have not signed up.

Tingo posted total revenue of $594 million in 2020, with $212 million EBITDA. As of December 31, 2020, Tingo has 9,344,000 subscribers. The company is confident that these figures will grow through its expansion across Africa and natural progression of business in Nigeria.

Businesses

Tingo has four core businesses:

  • Mobile Phone Leasing – Tingo has distributed almost 30 million mobile handsets since 2014 and will continue to replace the devices of its installed customer base every three years. Tingo Mobile provides the latest mobile phone handsets at an affordable price point and allows customers to spread payments over 36 months.
  • Mobile Voice and Data Service – Through a mobile virtual network, Tingo provides its customers with voice and data services, allowing customers to communicate effectively, both inside and outside the agricultural ecosystem.
  • Nwassa Marketplace Platform – Nwassa is Tingo’s proprietary agritech platform which provides Africa’s farmers with access to global markets to secure more competitive pricing for their crops. The platform processes 500,000 daily transactions with a value of over $8 million. A select group of trusted partners can assist smallholder farmers and agricultural cooperatives with packaging, warehousing, and dry and wet cargo logistics, as well as up-to-date information from the global agricultural sector. Tingo provides its customers with digital wallet services, which enable them to send and receive domestic payments, monitor cash flow in real time and securely hold money. The company also provides access to other services, such as utility bill payment, virtual airtime top-up, insurance services and alternative lending solutions.
  • TingoPay – Since the launch of the Nwassa platform, Tingo has been a dominant player in the B2B fintech vertical. After many successful months of operating Nwassa, Tingo entered the fintech B2C vertical to extend its B2B offering to a broader market beyond agriculture.

TingoPay is still in its beta phase and will launch in 2021 with a comprehensive marketing campaign. TingoPay offers the following services:

  • Tingo Wallet top-up
  • Peer to Peer payments, inclusive of merchant payments at the stores
  • Utility payments – airtime, broadband, cable, electricity, water, hotel, flights etc.
  • Pension payments
  • QR code payment services

Market Opportunity

Africa is the second-largest continent by population. It is also the youngest by far, with a median age of 18 for its 1.3 billion people. Tingo believes the building blocks for growth in Africa’s agriculture industry are in place and that the company is well positioned to participate in the upside. Sub-Saharan Africa’s population is growing at a rate of 2.7 percent per year. At the current growth rate, the continent’s population will double by 2050. Africa’s youthfulness represents a significant opportunity for material growth in demand for agricultural commodities. This younger generation is also being born into a digital world and is comfortable using technology.

Africa’s governments are improving business conditions for entrepreneurs and small businesses. Sub-Saharan Africa’s World Bank Doing Business rank has improved from 45 in 2004 to 65 in 2020. Tingo believes this trend will continue and encourage establishment of more new ventures across all economic sectors, including agriculture.

Africa attracted $407 billion of Foreign Direct Investments (“FDI”) between 2014 and 2018. Investments are increasingly focused on services and industrial sectors. Only 20 percent of investments are in extractive industries – a clear reversal from 2008, when 55 percent of FDI was aimed at resource extraction. Tingo believes FDI into Africa will help resolve significant infrastructure constraints and create value for agribusiness.

Management Team

Dozy Mmobuosi is the CEO of Tingo. He cofounded Tingo Mobile PLC (Nigeria) in 2001 and led the design and launch of Nigeria’s first SMS banking solution, which is still in use in the country today. He also headed a team of more than 120 Chinese and Nigerian engineers in the construction of two mobile phone assembly plants in Nigeria, which have produced and distributed 20 million phones across the country. He has led Tingo’s growth to more than $600 million in revenue annually. He holds a Ph.D. in Rural Advancement from UPM Malaysia.

Dakshesh Patel is the CFO of Tingo. He was formerly CFO of NatWest’s Global Debt and Investment Banking division. He has served as a Director at Gerken Capital Associates, a San Francisco-based alternative asset fund manager. He also led the restructure of Lloyds Banking Group (last financial crisis); managed integration of two leading shipping groups’ global treasury function to create world-leading shipping group Maersk Shipping; built three fintech companies; and exited one to Worldpay. Mr. Patel has strong banking experience, with a focus on Africa. He is a chartered accountant.

Chris Cleverly is president of Tingo. He has served as CEO of the Made in Africa Foundation, and as CEO of blockchain payments gateway startup Kamari. He has been a board member of several companies, both public and private, in the UK, India, China and Africa. He has advised multiple UK companies on their entrance into African markets, and regularly advises the UK Government on development issues and African governments on investment issues.

Clarence Simms is the Chief Technology Officer at Tingo. He has 25 years of IT and IT management experience. He has worked in IT Shared Services Technical Operations and IT Program Management for Huawei Technologies and MTN. As an entrepreneur, he created Africaprepay.com, a service that allows African Diaspora travelers to send airtime, pay bills, send mobile money and transfer money to a bank account from anyplace in the world.

Rory Bowen is the Chief of Staff at Tingo. Mr. Bowen started his career in traditional capital and derivatives markets working for Moneycorp and Tradition UK in European and emerging markets across FX, interest rate derivative and government bond markets. He has also spent time with one of Europe’s fastest growing fintech’s banking circles. Before joining Tingo, he was Chief of Staff at FinTech Alliance, an organization established in partnership with the UK Government Department for International Trade to foster innovation, growth and foreign direct investment (FDI) in the financial services sector and facilitate greater public/private cooperation.

Tingo Inc. (OTCQB: TMNA), closed Saturday's trading session at $1.49, off by 3.5599%, on 1,946 volume. The average volume for the last 3 months is 1,946 and the stock's 52-week low/high is $0.01/$6.00.

Recent News

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF)

The QualityStocks Daily Newsletter would like to spotlight Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF).

The U.S. Drug Enforcement Administration (DEA) has proposed a significant increase to the cannabis and psychedelics quota to be produced legally for research in 2023. In a new notice, the federal agency proposed that the new quota for marijuana be increased to 6.7 million grams. This is twice as much as its quota for 2022, which was 3.2 million grams, and more than three times its 2021 quota, which stood at 2 million grams. Increasing the marijuana quota will be easy, especially since the federal agency authorized additional marijuana manufacturers earlier this year. These approved producers can now apply for contracts to be federal cannabis suppliers for research purposes , under the National Institute on Drug Abuse. The DEA has also been increasing the production quota for psychedelics such as mescaline, LSD and psilocin, as interest in the therapeutic potential of these drugs increases. More localities and states enacting reforms these last few years have also played a role in this. These increased production quotas suggest that the academia and industry actors such as Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) are stepping up their efforts to study these substances and find ways through which they can be leveraged for human health.

Delic Holdings Corp. (CSE: DELC) (OTCQB: DELCF) is the leading psychedelic wellness platform, committed to bringing science-backed benefits to all and reframing the psychedelic conversation. The company owns and operates an umbrella of related businesses, including trusted media and e-commerce platforms like Reality Sandwich and Delic Radio; Delic Labs, the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology; Meet Delic, the premiere psychedelic wellness event; and Ketamine Infusion Centers, one of the largest ketamine clinics in the country.

Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and treatment options to the masses. Its founders helped build the multi-billion-dollar cannabis industry and aim to do the same in psychedelics as it follows a similar path toward legalization. In its quest to advance the new psychedelic renaissance upon us, Delic has become the pioneer in its field, creating an ecosystem of opportunities by investing in cutting-edge ideas.

The Vancouver-based company was formed in 2019 to address the growing interest in psychedelic wellness backed by science. Delic was the ‎first psychedelic umbrella platform. It is currently a trusted source for those interested in ‎psychedelic culture, education, treatments, and more.

While other emerging companies focus on patent medicine and big pharma for substances limited by government regulation, Delic is blazing a unique trail. It identifies ancillary and fully legal opportunities like IP, new media, live events, ketamine clinics (with the ability to offer additional psychedelic treatments once legalized, and large-scale production and brings them under its big tent of resources and reach.

The Big Problems Delic Is Addressing

  • Fifty percent of Americans will meet the criteria for a mental health condition sometime in their lifetime. The FDA has approved psilocybin therapy as a breakthrough therapy for depression.
  • Every 40 seconds, someone in the world commits suicide. Ketamine has been shown to decrease thoughts of suicide significantly. In 2019, the FDA approved esketamine as a fast-acting antidepressant.
  • Traditional palliative care methods do not eradicate end-of-life (EOL) anxiety. LSD and psilocybin have been shown to reduce EOL anxiety for terminally ill patients. Eighty percent of terminally ill patients with psilocybin sessions experienced significant reductions in depression and anxiety.
  • Approximately 50 million people in the U.S. are addicted to some tobacco product. Research shows that psilocybin is helping people quit smoking.

The Delic Ecosystem

The Delic Ecosystem covers three main areas: media, health, and science. The media focus is educating and motivating the masses through a variety of digital platforms, like Delic’s Reality Sandwich digital magazine, a free public education platform providing psychedelic guides, news and ‎culture (1.4+ million page views in 2020 and 54k social media followers across all platforms); Meet Delic, the first-ever psychedelic wellness summit and the premier psychedelic wellness event based in Las Vegas (over 2,000 live attendees and 5,000+ email subscribers); and Delic Radio (over 43 episodes and 100k total streams). Delic has also been featured in numerous media outlets like Forbes, NBC News, The Joe Rogan Experience, Daily Beast, High Times, and The Dr. Drew Podcast.

The focus of Delic’s health operations is the most accessible psychedelic treatments that can help billions of people live happier lives. Delic does this through one of the largest ketamine clinic chains in the country, Ketamine Infusion Centers (KICs), a limited liability corporation formed under the laws of Arizona that runs three ketamine clinics located in Bakersfield, California, and Phoenix, Arizona. Its management team has over 15 years of experience in the clinic and medical space, scaling and operating over 20 clinics, with a plan to open 10 more clinics in the next 18 months. Together, these clinics have overseen 4,000+ treatments delivered to date.

The focus of Delic’s science operations is developing IP and advanced extraction and testing facilities that are the backbone of the legal market. Delic carries this out through Delic Labs, a licensed cannabis and psilocybin research laboratory based in Vancouver. It’s the only entity licensed by Health Canada to exclusively focus on research and development of psilocybin vaporization technology.

Founded by award-winning chemists, Delic Labs focuses on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industries. Health Canada gave it a Section 56 Exemption to work with psilocybin compounds, allowing the company to possess and research these products for development and quality control before they hit the market.

Latest Acquisition – Homestead Book Company

On March 4, 2021, Delic announced its acquisition of Seattle-based Homestead Book Company. Homestead is a legacy counterculture distributor of psychedelic media. It’s also the creator of one of the first self-contained psilocybin mushroom grow kits.

The acquisition of Homestead is an exciting one, as it shows how Delic is increasing accessibility to this nascent industry within regulated jurisdictions. Homestead has sold tens of thousands of mushroom kits globally and was one of the earliest distributors for High Times and many other counterculture publications.

The Homestead acquisition allows Delic to increase its product offerings on its website, Reality Sandwich, which recently hit a record for average monthly traffic of over 200,000 unique visitors and over 2.6 million active readers in 2020.

Market Outlook

The psychedelic renaissance is here. Just in time to help address the global mental health crises, plant medicines have the potential to help billions of people live happier lives. Thanks to university-led and FDA-approved studies, North America is leading the way in advancing an industry as psychedelics are becoming accepted globally for therapeutic, medical, and recreational use. Here are some statistics:

  • 32 million people in the U.S. have used psychedelics at least once
  • 17% of all American adults between 21 and 64 have used psychedelics at least once
  • $500 billion is spent in the U.S. every year on prescription drugs
  • $238 billion is spent in the U.S. every year on mental health treatments and ancillary services
  • The anxiety disorder and depression treatment market is estimated at $16 billion
  • $187.8 billion was spent in 2013 on mental health and substance abuse disorders

Management Team

Delic Co-Founder and CCO Jackee Stang was an executive at High Times, a leading counterculture publication that became the voice for the cannabis industry. The monthly magazine had a circulation of over 500,000 copies per issue. Its website attracted 500,000 to five million users each month by 2014.

Likewise, company Co-Founder and CEO Matt Stang was a previous owner and operator of High Times, a position from which he played an instrumental in legalizing cannabis in multiple states and launched the Cannabis Cup in America. After interacting with the cannabis community for two decades, he helped found Delic in 2019 as one of the first psychedelic corporations. He shapes the company’s vision and path using his expertise in branding, marketing, business development, and product viability.

Delic’s VP of Business Development, John Coleman, Ph.D., is a former president of Anandia Labs, a biotech company focused on genetics and analytics. Having experience in both science and business, Dr. Coleman is well-equipped to lead Delic’s business development efforts as it strives to enter new vertical markets.

Zak Garcia is the company’s Chief Marketing Officer. He was the former CMO of Bulletproof Inc., maker of the well-known Bulletproof Coffee brand. Mr. Garcia is a marketing and leadership strategist who helped grow Bulletproof Coffee to over $250 million in revenue.

Delic Holdings Corp. (DELCF), closed Saturday's trading session at $0.03474, off by 6.3612%, on 26,140 volume. The average volume for the last 3 months is 26,140 and the stock's 52-week low/high is $0.03/$0.204.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.